Granulocyte colony-stimulating factor (G-CSF)-producing bladder cancer is rare, with only 75 cases reported in Japan. A 67-year-old woman was referred to our institution for the further examination of gross hematuria. Cystoscopy revealed a 7-cm bladder tumor. The initial white blood cell count was 17,100/μL, and a transurethral resected specimen showed G-CSF expression. CT revealed that the tumor had invaded the colon. As the patient had uncontrollable schizophrenia, radical cystectomy was abandoned. We herein report a case of G-CSF-producing bladder tumor.
Introduction
Granulocyte colony-stimulating factor (G-CSF) is a hematopoietic growth factor required for the proliferation and differentiation of hematopoietic precursors of neutrophil granulocytes [1] .
G-CSF-producing bladder tumor is still a rare entity, and only 75 cases have been reported in Japan, all showing a poor prognosis [2] [3] [4] [5] . Due to the rarity of this disease, there are no established treatments.
We herein report a rare case of G-CSF-producing bladder tumor.
Case Presentation
A 67-year-old woman was referred to our hospital for the further examination of gross hematuria. Cystoscopy revealed a 7-cm bladder tumor in her left bladder wall (Fig. 1) . Urinary cytology showed class IIIb. She had a history of schizophrenia for 45 years. Laboratory data showed almost normal findings, except for an elevated white blood cell (WBC) count (17,100/μL; Neutro 79.8%, Baso 1.1%, Eos 1.1%, Mono 6.8%, Lymph 11.2%). CT and MRI revealed a 2.2-cm left iliac lymph node metastasis and suspected colon invasion (Fig. 2) .
Two months after her initial visit, transurethral resection of bladder tumor (TUR-Bt) was performed. The tumor occupied from the left side wall to the anterior wall, with a 7-to 8-cm diameter. A pathological examination revealed highly invasive urothelial carcinoma with squamous cell differentiation (Grade 3, High Grade) with partial expression of G-CSF (Fig. 3) . Due to her schizophrenia and lymph node metastasis, she and her family sought no further treatment. She ultimately died of bladder cancer 6 months after her initial visit (Fig. 4) .
Discussion
Colony-stimulating factors promote WBC differentiation and proliferation through stem cells in the bone marrow [6] . G-CSF is one such colony-stimulating factor produced by macrophages and fibroblasts.
G-CSF-producing tumors secrete cytokines and increase the WBC count. The lung is the most frequent site of G-CSF-producing tumor formation, followed by the stomach, thyroid, and liver. G-CSF-producing tumors are diagnosed by the following four criteria: an elevated WBC count in the peripheral blood, an elevated serum G-CSF level, G-CSF expression in the tumor tissue, and a reduction in the WBC count or G-CSF expression in the serum following tumor resection or treatment [6] . Recent technology has facilitated the confirmation of the expression of G-CSF using an enzyme immunoassay (EIA) to detect serum G-CSF levels [3] . The present case showed an elevated WBC count, and immunohistochemistry detected G-CSF expression in the tumor tissue.
Previous reports have shown that the WBC count and serum G-CSF level were correlated with G-CSF-producing cancer progression, so these two factors have been considered tumor markers. Most reported G-CSF-producing tumors have shown a poor outcome. G-CSF-producing tumors tend to display G-CSF receptors, so autocrine tumor progression and resulting in introducing tumor progression.
A low pre-therapeutic serum G-CSF level and control of the WBC count after tumor resection are thought to be favorable outcome factors [7] . The present case showed a fever and elevated serum CRP level. While some previously reported cases have shown systemic inflammation, G-CSF itself does not induce a fever or CRP elevation. The mechanism underlying the appearance of a fever and CRP elevation is thought to involve the production of systemic cytokines, including IL-1 and IL-6, by this aggressive tumor. Some inflammation was also observed [4] .
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